Found 19 matching trials
To Evaluate the Effect and Safety of Telitacicept and Standard Treatment for 6months in IgA Nephropathy PHASE3 The purpose of this clinical study is to evaluate the efficacy and safety o...
Show More Status
Active Not Recruiting
Location
The First Affiliated hospital of Xuzhou Medical University
Learn More & Join Trial
A Study of the Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Inadequate Response to TNF-α Antagonists Due to Treat Moderate and Severe Rheumatoid Arthritis PHASE2 This is a phase Ⅱ, placebo-controlled, multicenter, dynamic randomized, dou...
Show More Location
Renji Hospital Shanghai Jiaotong University School of Medicine
Learn More & Join Trial
Telitacicept for PGNMID: A Single-Arm Study PHASE2 This single-center, prospective, single-arm study will evaluate the efficac...
Show More Status
Active Not Recruiting
Location
Peking University First Hospital, Renal Division
Learn More & Join Trial
A Study of RC18 Administered Subcutaneously to Subjects With Primary IgA(Immunoglobulin A) Nephropathy PHASE2 To evaluate the safety and efficacy of Tai Ai(Recombinant Human B Lymphocyt...
Show More Location
Peking University First Hospital.
Learn More & Join Trial
A Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Primary Sjögren's Syndrome PHASE2 The purpose of this study is to initially observe the safety and effectivit...
Show More Location
The First Affiliated Hospital of Bengbu Medical University
Learn More & Join Trial
A Study of TACI(Transmembrane Activator and Calcium-modulator and Cyclophilin Ligand (CAML) Interactor)-Antibody Fusion Protein Injection (RC18) in Subjects With Systemic Myasthenia Gravis PHASE2 The purpose of this study is to initially observe the safety and effectivit...
Show More Location
The First Affiliated Hospital of Bengbu Medical University
Learn More & Join Trial
Study of Recombinant Human B Lymphocyte(RC18) Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE) PHASE3 The purpose of this study is to initially access the safety and effectivity...
Show More Learn More & Join Trial
Efficacy and Immunological Evaluation of Telitacicept and Low Dose IL2 in the Treatment of Systemic Lupus Erythematosus PHASE3 The purpose of this study was to explore the clinical and immunological eff...
Show More Location
Department of Rheumatology and Immunology, Peking University People's Hospital
Learn More & Join Trial
Telitacicept Study in Chinese Subjects With Systemic Lupus Erythematosus PHASE1 This is a multi-center, open-label, phase I study....
Location
The First Affiliated Hospital of Bengbu Medical College
Learn More & Join Trial
Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients PHASE4 Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with ab...
Show More Location
Department of Rheumatology and Immunology, Xiangya Second Hospital, Central South University
Learn More & Join Trial